Filtered By:
Infectious Disease: Genital Warts
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 6492 results found since Jan 2013.
De-Escalation Treatment for Human Papillomavirus-Related Oropharyngeal Cancer: Questions for Practical Consideration
Oncology (Williston Park). 2023 Jul 21;37(7):281-287. doi: 10.46883/2023.25921000.ABSTRACTHuman papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (SCC), which accounts for an increasing proportion of all head and neck cancers, represents a specific entity with distinct clinical and molecular characteristics. It is now firmly established that patients with HPV-positive oropharyngeal SCC have a significantly improved prognosis because this variant has exquisite radiosensitivity compared with HPV-negative oropharyngeal SCC; thus, it can be targeted with de-escalated approaches using reduced doses of radiatio...
Source: Oncology (Williston Park, N.Y.) - July 27, 2023 Category: Cancer & Oncology Authors: Allen M Chen Source Type: research
Towards Formulation of Highly Acidic Active Ingredients: Development of Clinically Effective Concentrated Trichloroacetic Acid Gel for Wart Management
AAPS PharmSciTech. 2023 Jul 27;24(6):160. doi: 10.1208/s12249-023-02615-7.ABSTRACTCommon warts are benign skin lesions caused by the human papillomavirus. Although they are usually not harmful, they can cause pain, depending on their location. While many modalities are available for treatment of warts, none is a gold standard, and many are not affordable and/or have suboptimal outcomes. Trichloroacetic acid (TCA) is a chemical tissue-destroying agent used as a highly concentrated solution for wart management. While available and efficient, it is difficult to handle as the solution spreads to tissue surrounding the wart cau...
Source: AAPS PharmSciTech - July 27, 2023 Category: Drugs & Pharmacology Authors: Abdelrahman M Helmy Shimaa Shehata Ahmed Ramy M El Sabaa Hossam M Abdel-Wahab Sara A Abouelmagd Source Type: research
De-Escalation Treatment for Human Papillomavirus-Related Oropharyngeal Cancer: Questions for Practical Consideration
Oncology (Williston Park). 2023 Jul 21;37(7):281-287. doi: 10.46883/2023.25921000.ABSTRACTHuman papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (SCC), which accounts for an increasing proportion of all head and neck cancers, represents a specific entity with distinct clinical and molecular characteristics. It is now firmly established that patients with HPV-positive oropharyngeal SCC have a significantly improved prognosis because this variant has exquisite radiosensitivity compared with HPV-negative oropharyngeal SCC; thus, it can be targeted with de-escalated approaches using reduced doses of radiatio...
Source: Oncology (Williston Park, N.Y.) - July 27, 2023 Category: Cancer & Oncology Authors: Allen M Chen Source Type: research
